News
ANA Investigates (Podcast)
February 25, 2025
Parkinson’s Disease has long been a clinical diagnosis. But recently, there have been proposals to redefine the disease based on biomarkers of alpha-synucleinopathy and dopaminergic dysfunction. Parkinson’s Foundation National Medical Advisor, Dr. Michael S. Okun, joins host Dr. Christine Doss Esper to unpack both sides of this debate as the episode’s primary guests.